骨セメントおよび接着剤市場：骨セメント（PMMA、リン酸カルシウム）、骨接着剤（天然、合成）、荷重（抗生物質充填）、用途（人工関節置換術、骨形成術、椎体形成術）、エンドユーザー（病院、ASCS、クリニック）、地域別 - 2028年までの世界予測

Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) & Region - Global Forecast to 2028

世界の骨セメント・接着剤市場は、2023年の16億4,400万米ドルから2028年には22億4,800万米ドルに達すると予測され、予測期間中の年平均成長率は6.5%である。この市場の成長の主な原動力は、骨折や手術の増加、戦... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年8月1日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	184	199	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の骨セメント・接着剤市場は、2023年の16億4,400万米ドルから2028年には22億4,800万米ドルに達すると予測され、予測期間中の年平均成長率は6.5%である。この市場の成長の主な原動力は、骨折や手術の増加、戦略的提携やパートナーシップである。しかし、コストと手頃な価格に関する課題は、この市場の成長を脅かす可能性がある。

「膝関節全置換術は予測期間中に最も高い成長を遂げる。

人工関節置換術市場は、タイプ別に、膝関節全置換術、股関節全置換術、肩関節全置換術に区分される。
肩関節全置換術膝関節全置換術は予測期間中に最も高いCAGRで成長すると予測されている。変形性膝関節症の有病率の増加と高齢化により、世界中でTKA手術の件数が増加しており、これが骨接着剤とセメント市場を牽引している。

「欧州は予測期間中に3番目に高いCAGRを記録すると推定される。

本レポートでは、骨セメント・接着剤市場を4つの主要地域セグメントに区分しています：北米、欧州、アジア太平洋、その他の地域です。欧州市場は予測期間中に3番目に高い成長率を記録すると予測されています。この市場の成長の主な原動力は、65歳以上の人口の割合が高く、高齢化が著しいことである。高齢化社会では、変形性関節症や骨折などの整形外科疾患が発生しやすく、骨セメントや接着剤を使用した外科手術が必要になることが多い。

供給側の一次面接の内訳、企業タイプ別、呼称別、地域別：

- 企業タイプ別ティア1 (48%)、ティア2 (34%)、ティア3 (18%)

- 役職別Cレベル (33%), ディレクターレベル (40%), その他 (27%)

- 地域別北米 (36%)、ヨーロッパ (28%)、アジア太平洋 (20%)、その他の地域 (16%)

レポート掲載企業一覧

 Stryker（米国）
 ジマー・バイオメット（米国）
 デピュー・シンセ（ジョンソン・エンド・ジョンソンの子会社 - 米国）
 スミス+ネフュー（英国）
 アースレックス社（米国）
 エノビス（米国）
 グローバス・メディカル（米国）
 イグザクテック（米）
 ヘレウス・ホールディング（ドイツ）
 アーティビオン社（米）
 カーディナル・ヘルス(米国)
 テクニメド（フランス）
 メドトロニック（アイルランド）
 Tecres S.p.A.（イタリア）
 Bioceramed, S.A.（ポルトガル）
 Evolutis（フランス）
 Normmed Medical（トルコ）
 リナコル・メディカル（トルコ）
 BPB MEDICA（イタリア）
 IZI Medical（米国）
 アディタス・メディカル(ドイツ)
 OSARTIS GmbH（ドイツ）
 LDデイビス（米国）
 ミリガン＆ヒギンズ（米）
 VHERN srl（米国）

調査範囲
この調査レポートは、骨セメントと接着剤市場を製品別、地域別に調査しています。また、市場成長に影響を与える要因（促進要因、機会、課題、阻害要因など）を分析しています。利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争状況の詳細を提供します。また、微小市場についても、その成長動向、展望、骨セメント・接着剤市場全体への貢献に関して調査しています。主要5地域に関して、市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは、以下のポイントに関する洞察を提供します：

- 市場への浸透：骨セメント＆接着剤市場の上位25社が提供するバイオ除染製品に関する包括的な情報。骨セメント＆接着剤市場をタイプ別、地域別に分析しています。

- 市場促進要因：特定の市場の成長とパフォーマンスを刺激し、影響を与える要因や条件に関する包括的な情報。

- 市場開発：有利な新興市場に関する包括的情報。当レポートでは、主要地域にわたる様々な固定装置市場を分析しています。

- 市場の多様化：骨セメント・接着剤市場における未開拓の地域、最近の開発、投資に関する情報を網羅。

- 競争力の評価：骨セメント・接着剤市場における主要企業の市場シェアと戦略を詳細に評価します。

ページTOPに戻る

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 REGIONS COVERED 24
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 25
1.4 LIMITATIONS 25
1.5 STAKEHOLDERS 26
1.6 RECESSION IMPACT 26
2 RESEARCH METHODOLOGY 27
FIGURE 1 RESEARCH DESIGN 27
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 29
FIGURE 2 PRIMARY SOURCES 29
2.1.2.1 Breakdown of primary interviews 30
2.1.2.2 Key data from primary sources 31
2.2 MARKET SIZE ESTIMATION 32
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32
FIGURE 4 BOTTOM-UP APPROACH: PROCEDURE-BASED ANALYSIS 33
2.2.1 GROWTH FORECAST 33
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 34
FIGURE 6 TOP-DOWN APPROACH 34
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 35
FIGURE 7 DATA TRIANGULATION METHODOLOGY 35
2.4 ASSUMPTIONS 36
2.5 RECESSION IMPACT ANALYSIS 36
3 EXECUTIVE SUMMARY 37
FIGURE 8 BONE CEMENT & GLUE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 37
FIGURE 9 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 BONE CEMENT & GLUE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 38
FIGURE 11 BONE CEMENT & GLUE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 39
4 PREMIUM INSIGHTS 40
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BONE CEMENT & GLUE MARKET 40
FIGURE 12 GROWING GERIATRIC POPULATION TO DRIVE MARKET 40
4.2 BONE CEMENT MARKET, BY TYPE 41
FIGURE 13 PMMA CEMENT TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD 41
4.3 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE AND COUNTRY 42
FIGURE 14 US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2022 42
4.4 BONE CEMENT & GLUE MARKET, BY COUNTRY 43
FIGURE 15 INDIA AND CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
FIGURE 16 BONE CEMENT & GLUE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
5.2.1 DRIVERS 45
5.2.1.1 Growing incidence of sports injuries 45
5.2.1.2 Rapid growth in geriatric population 45
TABLE 1 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 (MILLION) 46
5.2.1.3 Developments in regenerative medicine 47
5.2.1.4 Growing number of road traffic accidents and other factors increasing surgery volumes 48
5.2.1.5 Technological advancements 48
5.2.2 RESTRAINTS 49
5.2.2.1 High costs and extensive clinical data requirements for launching new products 49
5.2.2.2 Alternatives to bone cement and glue 50
5.2.3 OPPORTUNITIES 51
5.2.3.1 Growth opportunities in emerging economies 51
5.2.3.2 Rising awareness and demand for minimally invasive procedures 51
5.2.4 CHALLENGES 52
5.2.4.1 Development of novel biomaterials with high mechanical properties and adhesion strength 52
5.2.4.2 Product-related complications 52
5.2.4.3 Unfavorable reimbursement scenario 53
6 BONE CEMENT & GLUE MARKET, BY TYPE 55
6.1 INTRODUCTION 56
TABLE 2 BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 56
6.2 BONE CEMENT 56
TABLE 3 CONSTITUENTS OF BONE CEMENT 57
TABLE 4 BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 57
6.2.1 BONE CEMENT MARKET, BY TYPE 57
TABLE 5 BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 58
6.2.1.1 PMMA cement 58
6.2.1.1.1 Wide usage and properties of PMMA to drive market 58
TABLE 6 PMMA CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 58
6.2.1.2 Calcium phosphate cement 59
6.2.1.2.1 High biocompatibility and radiopacity to drive adoption 59
TABLE 7 CPC MARKET, BY REGION, 2021–2028 (USD MILLION) 59
6.2.1.3 Glass polyalkenoate cement 59
6.2.1.3.1 Wide applications in dentistry to drive market 59
TABLE 8 GPC MARKET, BY REGION, 2021–2028 (USD MILLION) 60
6.2.2 BONE CEMENT MARKET, BY LOADING 60
TABLE 9 BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 60
6.2.2.1 Antibiotic-loaded bone cement 61
6.2.2.1.1 High risk of developing deep infections during surgeries to support adoption 61
TABLE 10 ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 61
6.2.2.2 Non-antibiotic-loaded bone cement 61
6.2.2.2.1 Low cost and less-stringent regulations to support usage 61
TABLE 11 NON-ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 62
6.3 BONE GLUE 62
TABLE 12 BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 63
TABLE 13 BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 63
6.3.1 NATURAL BONE GLUE 63
6.3.1.1 High biocompatibility to support greater adoption 63
TABLE 14 NATURAL BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 64
6.3.2 SYNTHETIC BONE GLUE 64
6.3.2.1 Emerging medical applications indicate high potential of synthetic glue 64
TABLE 15 SYNTHETIC BONE GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 64
7 BONE CEMENT & GLUE MARKET, BY APPLICATION 65
7.1 INTRODUCTION 66
TABLE 16 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 66
7.2 ARTHROPLASTY 66
TABLE 17 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 67
TABLE 18 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 67
7.2.1 TOTAL KNEE ARTHROPLASTY 67
7.2.1.1 TKA to hold largest arthroplasty market share 67
TABLE 19 BONE CEMENT & GLUE MARKET FOR TOTAL KNEE ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 68
7.2.2 TOTAL HIP ARTHROPLASTY 68
7.2.2.1 Growing geriatric population to boost procedural volumes 68
TABLE 20 BONE CEMENT & GLUE MARKET FOR TOTAL HIP ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 69
7.2.3 TOTAL SHOULDER ARTHROPLASTY 69
7.2.3.1 Rising sports injury incidence to drive market 69
TABLE 21 BONE CEMENT & GLUE MARKET FOR TOTAL SHOULDER ARTHROPLASTY, BY REGION, 2021–2028 (USD MILLION) 70
7.3 KYPHOPLASTY 70
7.3.1 INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET 70
TABLE 22 TOP TEN COUNTRIES IN KYPHOPLASTY RESEARCH 71
TABLE 23 BONE CEMENT & GLUE MARKET FOR KYPHOPLASTY, BY REGION, 2021–2028 (USD MILLION) 71
7.4 VERTEBROPLASTY 71
7.4.1 RISING INCIDENCE OF VERTEBRAL COMPRESSION FRACTURES TO SUPPORT MARKET GROWTH 71
TABLE 24 BONE CEMENT & GLUE MARKET FOR VERTEBROPLASTY, BY REGION, 2021–2028 (USD MILLION) 72
7.5 OTHER APPLICATIONS 72
TABLE 25 BONE CEMENT & GLUE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 73
8 BONE CEMENT & GLUE MARKET, BY END USER 74
8.1 INTRODUCTION 75
TABLE 26 BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 75
8.2 HOSPITALS & ASCS 75
8.2.1 HOSPITALS & ASCS TO DOMINATE END-USER MARKET 75
TABLE 27 BONE CEMENT & GLUE MARKET FOR HOSPITALS & ASCS, BY REGION, 2021–2028 (USD MILLION) 76
8.3 CLINICS & PHYSICIAN OFFICES 76
8.3.1 RISING PREFERENCE FOR CLINICS AND COST-SAVING POTENTIAL TO DRIVE MARKET 76
TABLE 28 BONE CEMENT & GLUE MARKET FOR CLINICS & PHYSICIAN OFFICES, BY REGION, 2021–2028 (USD MILLION) 77
9 BONE CEMENT & GLUE MARKET, BY REGION 78
9.1 INTRODUCTION 79
TABLE 29 BONE CEMENT & GLUE MARKET, BY REGION, 2021–2028 (USD MILLION) 79
9.2 NORTH AMERICA 80
9.2.1 NORTH AMERICA: RECESSION IMPACT 80
FIGURE 17 NORTH AMERICA: BONE CEMENT & GLUE MARKET SNAPSHOT 81
TABLE 30 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 31 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 32 NORTH AMERICA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 33 NORTH AMERICA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 83
TABLE 34 NORTH AMERICA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
TABLE 35 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 83
TABLE 36 NORTH AMERICA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 84
TABLE 37 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 84
9.2.2 US 84
9.2.2.1 Growing geriatric population and high prevalence of sports injuries to drive market 84
FIGURE 18 TOTAL ESTIMATED INJURIES BY SPORTS ACTIVITY IN 2021 85
TABLE 38 US: KEY MACROINDICATORS 86
TABLE 39 US: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 40 US: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 41 US: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 87
TABLE 42 US: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 87
TABLE 43 US: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 87
TABLE 44 US: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 45 US: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 88
9.2.3 CANADA 89
9.2.3.1 Availability of government funding and growth in geriatric population to drive market 89
TABLE 46 FUNDS FOR SPORTS ORGANIZATIONS, 2021/2022 (USD THOUSAND) 89
TABLE 47 CANADA: KEY MACROINDICATORS 89
TABLE 48 CANADA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 49 CANADA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 50 CANADA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 90
TABLE 51 CANADA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 52 CANADA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 91
TABLE 53 CANADA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 54 CANADA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 92
9.3 EUROPE 92
TABLE 55 EUROPE: BURDEN OF OSTEOPOROSIS (2021) 92
9.3.1 EUROPE: RECESSION IMPACT 93
TABLE 56 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 57 EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 58 EUROPE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 59 EUROPE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 94
TABLE 60 EUROPE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 61 EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 62 EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 95
TABLE 63 EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 95
9.3.2 FRANCE 96
9.3.2.1 Rising government support to drive demand 96
TABLE 64 FRANCE: KEY MACROINDICATORS 96
TABLE 65 FRANCE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 66 FRANCE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 67 FRANCE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 97
TABLE 68 FRANCE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 69 FRANCE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 98
TABLE 70 FRANCE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 71 FRANCE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 98
9.3.3 GERMANY 99
9.3.3.1 Robust healthcare spending and advanced healthcare system to favor market growth 99
TABLE 72 GERMANY: KEY MACROINDICATORS 99
TABLE 73 GERMANY: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 74 GERMANY: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 75 GERMANY: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 100
TABLE 76 GERMANY: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 77 GERMANY: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 101
TABLE 78 GERMANY: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 79 GERMANY: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 102
9.3.4 UK 102
9.3.4.1 Presence of strong healthcare infrastructure and high burden of orthopedic cases 102
TABLE 80 UK: KEY MACROINDICATORS 103
TABLE 81 UK: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 82 UK: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 83 UK: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 104
TABLE 84 UK: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 85 UK: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 86 UK: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 87 UK: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 105
9.3.5 REST OF EUROPE 105
TABLE 88 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP) 106
TABLE 89 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 90 REST OF EUROPE: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 91 REST OF EUROPE: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 107
TABLE 92 REST OF EUROPE: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 93 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 94 REST OF EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 95 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 109
9.4 ASIA PACIFIC 109
9.4.1 ASIA PACIFIC: RECESSION IMPACT 109
FIGURE 19 ASIA PACIFIC: BONE CEMENT & GLUE MARKET SNAPSHOT 110
TABLE 96 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 111
TABLE 97 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 98 ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 99 ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 112
TABLE 100 ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 101 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
TABLE 102 ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 103 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 113
9.4.2 CHINA 113
9.4.2.1 China to hold largest market share in APAC 113
TABLE 104 CHINA: KEY MACROINDICATORS 114
TABLE 105 INCIDENCE OF OSTEOPOROTIC FRACTURES IN CHINA, 2015–2035 114
TABLE 106 CHINA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 107 CHINA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 108 CHINA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 115
TABLE 109 CHINA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 110 CHINA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 111 CHINA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 112 CHINA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.4.3 INDIA 117
9.4.3.1 Rising medical tourism, improving healthcare infrastructure, and growing population to drive market 117
TABLE 113 INDIA: KEY MACROINDICATORS 117
TABLE 114 INDIA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 115 INDIA: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 116 INDIA: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 118
TABLE 117 INDIA: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 118 INDIA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 119 INDIA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 120 INDIA: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 119
9.4.4 JAPAN 120
9.4.4.1 Large aging population and favorable government initiatives to drive market 120
TABLE 121 JAPAN: KEY MACROINDICATORS 120
TABLE 122 JAPAN: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 123 JAPAN: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 124 JAPAN: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 121
TABLE 125 JAPAN: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 126 JAPAN: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
TABLE 127 JAPAN: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 128 JAPAN: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 122
9.4.5 REST OF ASIA PACIFIC 123
TABLE 129 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 130 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 131 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 124
TABLE 132 REST OF ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 133 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 134 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 135 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 126
9.5 REST OF THE WORLD 126
TABLE 136 US VS. MEXICO: AVERAGE COST COMPARISON (USD) 127
9.5.1 ROW: RECESSION IMPACT 127
TABLE 137 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 138 REST OF THE WORLD: BONE CEMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 139 REST OF THE WORLD: BONE CEMENT MARKET, BY LOADING, 2021–2028 (USD MILLION) 128
TABLE 140 REST OF THE WORLD: BONE GLUE MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 141 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 142 REST OF THE WORLD: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 143 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY END USER, 2021–2028 (USD MILLION) 130
10 COMPETITIVE LANDSCAPE 131
10.1 OVERVIEW 131
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 131
TABLE 144 OVERVIEW OF STRATEGIES ADOPTED BY KEY BONE CEMENT & GLUE MARKET PLAYERS 131
10.3 MARKET SHARE ANALYSIS, 2022 132
FIGURE 20 BONE CEMENT & GLUE MARKET SHARE ANALYSIS, 2022 132
TABLE 145 BONE CEMENT & GLUE MARKET: DEGREE OF COMPETITION (2022) 132
10.4 REVENUE SHARE ANALYSIS, 2022 133
FIGURE 21 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (USD MILLION) 133
10.5 COMPANY EVALUATION MATRIX, 2022 134
10.5.1 STARS 134
10.5.2 EMERGING LEADERS 134
10.5.3 PERVASIVE PLAYERS 134
10.5.4 PARTICIPANTS 134
FIGURE 22 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX (2022) 135
10.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022 135
10.6.1 PROGRESSIVE COMPANIES 135
10.6.2 STARTING BLOCKS 136
10.6.3 RESPONSIVE COMPANIES 136
10.6.4 DYNAMIC COMPANIES 136
FIGURE 23 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 136
10.7 COMPETITIVE BENCHMARKING 137
TABLE 146 BONE CEMENT & GLUE MARKET: DETAILED LIST OF KEY SMES/STARTUPS 137
10.8 COMPANY FOOTPRINT ANALYSIS 137
TABLE 147 COMPANY FOOTPRINT ANALYSIS 137
TABLE 148 COMPANY PRODUCT FOOTPRINT 138
TABLE 149 COMPANY REGIONAL FOOTPRINT 139
10.9 COMPETITIVE SCENARIO 140
10.9.1 DEALS 140
TABLE 150 DEALS 140
10.9.2 OTHER DEVELOPMENTS 141
TABLE 151 OTHER DEVELOPMENTS 141
11 COMPANY PROFILES 142
11.1 KEY PLAYERS 142
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER 142
TABLE 152 STRYKER: BUSINESS OVERVIEW 142
FIGURE 24 STRYKER: COMPANY SNAPSHOT (2022) 143
11.1.2 ZIMMER BIOMET 146
TABLE 153 ZIMMER BIOMET: BUSINESS OVERVIEW 146
FIGURE 25 ZIMMER BIOMET: COMPANY SNAPSHOT (2022) 147
11.1.3 HERAEUS HOLDING 149
TABLE 154 HERAEUS HOLDING: BUSINESS OVERVIEW 149
11.1.4 SMITH+NEPHEW 151
TABLE 155 SMITH+NEPHEW: BUSINESS OVERVIEW 151
FIGURE 26 SMITH & NEPHEW: COMPANY SNAPSHOT (2022) 152
11.1.5 DEPUY SYNTHES (JOHNSON & JOHNSON) 154
TABLE 156 JOHNSON & JOHNSON: BUSINESS OVERVIEW 154
FIGURE 27 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 155
11.1.6 ENOVIS 157
TABLE 157 ENOVIS: BUSINESS OVERVIEW 157
FIGURE 28 ENOVIS: COMPANY SNAPSHOT (2022) 157
11.1.7 ARTIVION, INC. 159
TABLE 158 ARTIVION, INC.: BUSINESS OVERVIEW 159
FIGURE 29 ARTIVION, INC.: COMPANY SNAPSHOT (2022) 160
11.1.8 CARDINAL HEALTH 161
TABLE 159 CARDINAL HEALTH: BUSINESS OVERVIEW 161
FIGURE 30 CARDINAL HEALTH.: COMPANY SNAPSHOT (2022) 162
11.1.9 MEDTRONIC 163
TABLE 160 MEDTRONIC: BUSINESS OVERVIEW 163
FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT (2022) 164
11.1.10 GLOBUS MEDICAL 165
TABLE 161 GLOBUS MEDICAL: BUSINESS OVERVIEW 165
FIGURE 32 GLOBUS MEDICAL: COMPANY SNAPSHOT (2022) 166
11.1.11 EXACTECH, INC. 168
TABLE 162 EXACTECH, INC.: BUSINESS OVERVIEW 168
11.1.12 ARTHREX, INC. 169
TABLE 163 ARTHREX, INC.: BUSINESS OVERVIEW 169
11.1.13 TEKNIMED 170
TABLE 164 TEKNIMED: BUSINESS OVERVIEW 170
11.1.14 TECRES S.P.A. 171
TABLE 165 TECRES S.P.A.: BUSINESS OVERVIEW 171
11.1.15 BIOCERAMED S.A. 172
TABLE 166 BIOCERAMED, S.A.: BUSINESS OVERVIEW 172
11.1.16 EVOLUTIS 173
TABLE 167 EVOLUTIS: BUSINESS OVERVIEW 173
11.2 OTHER PLAYERS 174
11.2.1 NORMMED MEDICAL 174
11.2.2 LINACOL MEDICAL INC. 174
11.2.3 BPB MEDICA 175
11.2.4 IZI MEDICAL 175
11.2.5 ADITUS MEDICAL 176
11.2.6 OSARTIS GMBH 176
11.2.7 LD DAVIS 177
11.2.8 MILLIGAN & HIGGINS 177
11.2.9 VHERN S.R.L. 178
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 179
12.1 INDUSTRY INSIGHTS 179
12.2 DISCUSSION GUIDE 180
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 184
12.4 CUSTOMIZATION OPTIONS 186
12.5 RELATED REPORTS 187
12.6 AUTHOR DETAILS 188

ページTOPに戻る

Table of Contents

Summary

The global Bone Cement & Glue Market is projected to reach USD 2,248 million by 2028 from USD 1,644 million in 2023, at a CAGR of 6.5% during the forecast period. The growth of this market is majorly driven by Increasing number of bone fractures and surgeries and Strategic Collaborations and Partnerships. However, Challenges associated with cost and affordability may threat the growth of this market.

“Total knee arthroplasty in the type of segment to witness the highest growth during the forecast period.”

Based on the Type, the arthroplasty market is segmented into Total knee arthroplasty, Total hip arthroplasty
Total shoulder arthroplasty. Total knee arthroplasty is projected to grow at the highest CAGR during the forecast period. The significant factors contributing to the growth of this market is The increasing prevalence of knee osteoarthritis and the aging population have contributed to a growing number of TKA procedures worldwide which drives the bone glue and cement market.

“Europe is estimated to register the third highest CAGR during the forecast period.”

In this report, the Bone cement & glue market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the third highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of significant aging population, with a higher proportion of individuals aged 65 and above. The aging demographic is more prone to orthopedic conditions, such as osteoarthritis and fractures, which often require surgical interventions using bone cement and glue, High Prevalence of Orthopedic Conditions, Growing Number of Orthopedic Surgeries, and Technological Advancements in healthcare sectors.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (48%), Tier 2 (34%), and Tier 3 (18%)

• By Designation: C-level (33%), Director-level (40%), and Others (27%)

• By Region: North America (36%), Europe (28%), AsiaPacific (20%), Rest of the World (16%)

List of Companies Profiled in the Report

 Stryker (US)
 Zimmer Biomet (US)
 DePuy Synthes (a subsidiary of Johnson & Johnson - US)
 Smith+Nephew.(UK)
 Arthrex, Inc. (US)
 Enovis (US)
 Globus Medical (US)
 Exactech, Inc.(US)
 Heraeus Holding (Germany)
 Artivion, Inc (US)
 Cardinal Health. (US)
 Teknimed (France)
 Medtronic (Ireland)
 Tecres S.p.A.(Italy)
 Bioceramed, S.A. (Portugal)
 Evolutis (France)
 Normmed Medical (Turkey)
 LINACOL Medical (Turkey)
 BPB MEDICA (Italy)
 IZI Medical (US)
 Aditus Medical. (Germany)
 OSARTIS GmbH (Germany)
 LD Davis (US)
 Milligan & Higgins (US)
 VHERN srl (US)

Research Coverage:
This report studies the Bone cement & glue market based on product and region. The report also analyzes factors (such as drivers, opportunities, and challenges, restraints) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total Bone cement & glue market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on bio decontamination products offered by the top 25 players in the Bone cement & glue market. The report analyzes the Bone cement & glue market by Type, and region.

• Market Drivers: Comprehensive information about the factors and conditions that stimulate and influence the growth and performance of a specific market.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Bone cement & glue market.

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the Bone cement & glue market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（bone cement）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（bone cement）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?